Literature DB >> 12947998

The WHO ARIA (allergic rhinitis and its impact on asthma) initiative.

C Bachert1, P van Cauwenberge.   

Abstract

The ARIA working group, in collaboration with the WHO in Geneva, recently published a state-of-the-art review and recommendations derived from it on the link between rhinitis and asthma. Rhinitis is the most frequent manifestation of allergic disease in humans and is often linked to other atopic diseases such as food allergy, atopic dermatitis or asthma, and may furthermore have an impact on the sinuses. ARIA focuses on one of the most important of the mentioned issues, the link between upper and lower airways in allergic disease. To facilitate understanding between the otorhinolaryngologist and the pulmonologist, the classification of rhinitis has been adapted to that of asthma, and the terms 'intermittent' and 'persistent' allergic rhinitis have been introduced. Elaborate guidelines for the diagnosis and assessment of the severity of disease are provided, and detailed recommendations for the management of rhinitis and asthma are suggested with a special focus on specific immunotherapy.

Entities:  

Mesh:

Year:  2003        PMID: 12947998     DOI: 10.1159/000071546

Source DB:  PubMed          Journal:  Chem Immunol Allergy        ISSN: 0079-6034


  8 in total

1.  Examining the utilization and tolerability of the non-sedating antihistamine levocetirizine in England using prescription-event monitoring data.

Authors:  Deborah Layton; Vicki Osborne; Anna Gilchrist; Saad A W Shakir
Journal:  Drug Saf       Date:  2011-12-01       Impact factor: 5.606

2.  Comparison of the risk of drowsiness and sedation between levocetirizine and desloratadine: a prescription-event monitoring study in England.

Authors:  Deborah Layton; Lynda Wilton; Andrew Boshier; Victoria Cornelius; Scott Harris; Saad A W Shakir
Journal:  Drug Saf       Date:  2006       Impact factor: 5.606

3.  Association of allergic rhinitis with pesticide use among grape farmers in Crete, Greece.

Authors:  Leda Chatzi; Athanasios Alegakis; Nikolaos Tzanakis; Nikolaos Siafakas; Manolis Kogevinas; Christos Lionis
Journal:  Occup Environ Med       Date:  2006-12-20       Impact factor: 4.402

4.  Examining the tolerability of the non-sedating antihistamine desloratadine: a prescription-event monitoring study in England.

Authors:  Deborah Layton; Lynda Wilton; Saad A W Shakir
Journal:  Drug Saf       Date:  2009       Impact factor: 5.606

5.  Characteristics of patients receiving allergy vaccination: to which extent do socio-economic factors play a role?

Authors:  Karin Dam Petersen; Christian Kronborg; Dorte Gyrd-Hansen; Ronald Dahl; Jørgen Nedergaard Larsen; Allan Linneberg
Journal:  Eur J Public Health       Date:  2010-05-19       Impact factor: 3.367

6.  Sibship and Self-esteem in Children with Asthma.

Authors:  Concetta Polizzi; Valentina Fontana; Antonio Carollo; Alessandra Bono; Sofia Burgio; Giovanna Perricone
Journal:  Pediatr Rep       Date:  2016-06-23

Review 7.  Guidance to 2018 good practice: ARIA digitally-enabled, integrated, person-centred care for rhinitis and asthma.

Authors:  J Bousquet; A Bedbrook; W Czarlewski; G L Onorato; S Arnavielhe; D Laune; E Mathieu-Dupas; J Fonseca; E Costa; O Lourenço; M Morais-Almeida; A Todo-Bom; M Illario; E Menditto; G W Canonica; L Cecchi; R Monti; L Napoli; M T Ventura; G De Feo; W J Fokkens; N H Chavannes; S Reitsma; A A Cruz; J da Silva; F S Serpa; D Larenas-Linnemann; J M Fuentes Perez; Y R Huerta-Villalobos; D Rivero-Yeverino; E Rodriguez-Zagal; A Valiulis; R Dubakiene; R Emuzyte; V Kvedariene; I Annesi-Maesano; H Blain; P Bonniaud; I Bosse; Y Dauvilliers; P Devillier; J F Fontaine; J L Pépin; N Pham-Thi; F Portejoie; R Picard; N Roche; C Rolland; P Schmidt-Grendelmeier; P Kuna; B Samolinski; J M Anto; V Cardona; J Mullol; H Pinnock; D Ryan; A Sheikh; S Walker; S Williams; S Becker; L Klimek; O Pfaar; K C Bergmann; R Mösges; T Zuberbier; R E Roller-Wirnsberger; P V Tomazic; T Haahtela; J Salimäki; S Toppila-Salmi; E Valovirta; T Vasankari; B Gemicioğlu; A Yorgancioglu; N G Papadopoulos; E P Prokopakis; I G Tsiligianni; S Bosnic-Anticevich; R O'Hehir; J C Ivancevich; H Neffen; M E Zernotti; I Kull; E Melén; M Wickman; C Bachert; P W Hellings; G Brusselle; S Palkonen; C Bindslev-Jensen; E Eller; S Waserman; L P Boulet; J Bouchard; D K Chu; H J Schünemann; M Sova; G De Vries; M van Eerd; I Agache; I J Ansotegui; M Bewick; T Casale; M Dykewick; M Ebisawa; R Murray; R Naclerio; Y Okamoto; D V Wallace
Journal:  Clin Transl Allergy       Date:  2019-03-11       Impact factor: 5.871

8.  Patient related outcomes in a real life prospective follow up study: Allergen immunotherapy increase quality of life and reduce sick days.

Authors:  Karin D Petersen; Christian Kronborg; Jørgen N Larsen; Ronald Dahl; Dorte Gyrd-Hansen
Journal:  World Allergy Organ J       Date:  2013-09-09       Impact factor: 4.084

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.